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SUMMARY   
There were 508 new diagnoses of HIV in Ireland in 2016, representing a rate of 10.7 per 
100,000 population. The total number of HIV diagnoses increased by 5% between 2015 and 
2016.   
 
However, excluding those with a previous HIV diagnosis, the number of diagnoses decreased 
by 6% in 2016, which is a welcome reduction. An increasing proportion (34%) of diagnoses in 
Ireland in 2016 were in persons known to be previously diagnosed HIV positive abroad, and 
the majority of these (86%) had transferred their care to Ireland. This proportion has 
increased from 21% in 2012 (when data collection of this variable started).  
 
Of the 508 new diagnoses, just over half (51%) were among men who have sex with men 
(MSM). This was the largest number of diagnoses ever reported in MSM, who remain the 
subgroup most affected by HIV in Ireland. Similar to what was seen overall, the proportion of 
MSM previously diagnosed HIV positive before arrival in Ireland has been increasing and was 
42% in 2016 compared to 16% in 2012. The majority of these men (87%) were born abroad, 
with the highest number from Latin America. Similarly the numbers of new diagnoses in MSM 
not previously diagnosed abroad dropped by 14%  in 2016 compared to 2015.  
 
Given these increasing proportions of cases new to Ireland who are already known to be HIV 
positive, it is essential to focus on early engagement in care and immediate initiation of 
antiretroviral therapy (ART) for clinical benefits, but also to prevent onward transmission. This 
is in line with advice from the World Health Organisation (WHO) and the recently published 
national recommendation from the HSE that patients start ART at diagnosis regardless of CD4 
count (1, 2).  Effective HIV treatment resulting in undetectable viral loads is protective in 
preventing passing on the virus to others (3). 
  
Twenty eight percent of diagnoses were among heterosexuals, with 64% of heterosexual 
cases born in sub-Saharan Africa. People from sub-Saharan Africa presented later in the 
course of their HIV infection than all other groups and additional strategies are urgently 
needed to reduce the proportion presenting with late diagnosis and advanced disease in this 
group.  
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There were 21 diagnoses among people who inject drugs (PWID), a decrease from the 
numbers in 2014 and 2015 when there was an outbreak of HIV in Dublin among homeless 
drug users (4, 5).  
 
Data on CD4 count at this diagnosis was available for less than two thirds of the new 
diagnoses in 2016 which makes the analysis of data on stage of infection difficult. Thirty seven 
percent of all people diagnosed in 2016 presented late and among those without a history of 
previously diagnosed HIV abroad, 44% presented late. Groups where additional efforts are 
needed to detect HIV infection earlier are those from sub-Saharan Africa and those aged over 
40 years.  
 
Combination HIV prevention approaches are needed to halt transmission of HIV . This includes 
HIV testing, counselling, condoms, post-exposure prophylaxis (PEP), sexual health services, the 
use of antiretroviral therapy treatment as prevention (TasP),  and harm reduction 
interventions for people who use drugs, all of which are currently provided. In addition, a 
national working group is reviewing  the role, cost and benefits of including pre-exposure 
prophylaxis (PrEP) as one of these approaches. 
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1. HIV DIAGNOSES - 2016 
There were 508 new HIV diagnoses notified in Ireland in 2016, a notification rate of 10.7 per 
100,000 population1. This is a 5% increase compared to 2015. However, of the 508 diagnoses, 
34% had previously been diagnosed HIV positive in another country and the majority of these 
(86%) were transferring their HIV care to Ireland.  
 
Table 1 gives a summary of the 2016 notifications of HIV. Since the early 1980’s and to the end 
of 2016, 8,341 people have been diagnosed with HIV in Ireland.  However, this number does 
not represent the number of people living with HIV (PLHIV) in Ireland, as it does not take 
factors such as death and migration into account.  
 
Completed enhanced surveillance forms were received for 83% (n=418) of diagnoses in 2016 
(as of 23rd August 2017). Data completeness of key variables is described in Table A1 in the 
Appendix. Further data completeness reports are available here.  
 
Between 2014 and 2015, there was a large increase in notifications (30%) followed by a 
smaller increase (5%) between 2015 and 2016 (figure 1). However, a change in the case 
definition for surveillance which was introduced in 2015 in HSE East (Dublin, Kildare and 
Wicklow) and to all other areas in 2016 improved both the timeliness of notifications and 
resulted in an increase in the number of notifications (see technical note on page 21).  
 
 
 
 
 
 
  
 
 
 
                                                                
1
Based on 2016 census 
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Table 1: Summary of 2016 HIV data 
Number of HIV diagnoses 508 
Rate of diagnoses (per 100,000 population) 10.7 
Gender Males (%) 77.4 
Females (%) 22.6 
Male to female ratio 3.4 
Age Median age of adult cases (years) 35 
Age range of adult cases (years) 18-72 
Young people aged 15-24 years (%) 7.9 
Aged 50 and older (%) 9.5 
Probable Route of Transmission MSM (%) 51.4 
Heterosexual (%) 27.6 
Injecting Drug Use (%) 4.1 
Mother to Child transmission (%) 0.6 
Other (%) 0.4 
Unknown (%) 15.2 
Region of Birth Born in Ireland (%) 25.4 
Born Abroad (%) 61.2 
Unknown (%) 13.4 
Co-infections Acute STI (%) 13.0 
TB (%) 2.4 
Previous history of testing Previously tested positive abroad (%) 34.4 
Transfer of care overall (% among those 
previously positive abroad) 
29.1 (86.3%) 
 
 
Figure 1: HIV diagnoses and diagnosis rate per 100,000, 2003 to 2016 
0
100
200
300
400
500
600
0.0
2.0
4.0
6.0
8.0
10.0
12.0
2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016
N
u
m
b
e
r 
o
f 
n
o
ti
fi
c
a
ti
o
n
s
 
N
o
ti
fi
c
a
ti
o
n
 r
a
te
 p
e
r 
1
0
0
,0
0
0
 
Year 
Notifications Notification rate
  
8 
 
1.1 GENDER AND AGE 
In 2016, 77% of HIV diagnoses were in men and 23% were in women, with a male to female 
ratio of 3.4. The median age of adult cases at HIV diagnosis was 35 years (range: 18 to 72 
years); 35 years in men (range: 19-74 years) and women (range: 19 to 63 years). The highest 
proportion of diagnoses (43%) was in those aged 30-39 year olds. Eight percent of cases were 
in young people (15-24 years of age) and 10% were in those aged 50 and older (see Table 2).  
 
Table 2: HIV diagnoses by age group and gender, 2016 
Age Group (yrs) Male Female Total 
 N % N % N % 
<15 0 0.0 1 0.9 1 0.2 
15-19 2 0.5 2 1.7 4 0.8 
20-24  28 7.1 8 7.0 36 7.1 
25-29  76 19.3 14 12.2 90 17.7 
30-34 85 21.6 25 21.7 110 21.7 
35-39  73 18.6 36 31.3 109 21.5 
40-44 50 12.7 10 8.7 60 11.8 
45-49  38 9.7 12 10.4 50 9.8 
50+ 41 10.4 7 6.1 48 9.5 
Total 393 100.0 115 100.0 508 100.0 
 
The rate of diagnoses among men was 17.3 per 100,000 male population compared to 5.0 per 
100,000 female population among women. Men had higher age-specific rates than women in 
all age groups (see Figure 2).  
 
 
Figure 2: Gender and age specific HIV notification rates  (per 100,000 population), 2016 
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1.2 PROBABLE ROUTE OF TRANSMISSION 
Information on probable route of transmission was available for 84% (n=427) of diagnoses in 
2016. Among all notifications, sex between men was the predominant mode of HIV 
transmission (51%), followed by heterosexual transmission (28%). Four percent were among 
people who inject drugs (PWID). There were three cases where the route of transmission was 
reported as mother to child transmission (MTCT). Two had previously been diagnosed HIV 
positive abroad and the third was a baby born in Ireland in 20162. Further information on 
diagnoses in MSM, heterosexuals and PWID is available on pages 18-20.  
 
Since 2005, the number of diagnoses among MSM has increased over four-fold (see Table 3; 
Figure 3). The number of cases among heterosexuals has remained stable since 2010 with 
between 125 and 140 cases per year. The number among PWID increased sharply in 2015 due 
to an outbreak of HIV among PWID (1, 2) but decreased in 2016.  
 
Table 3: HIV diagnoses by probable route of transmission, 2003 to 2016 
Prob route 
transmission 
MSM PWID Hetero MCT Unk/Other Total 
 No.  % No.  % No.  % No.  % No.  %  
2003 76 19.0 50 12.5 222 55.4 11 2.7 42 10.5 401 
2004 63 17.6 74 20.7 179 50.0 3 0.8 39 10.9 358 
2005 60 18.4 67 20.6 171 52.5 3 0.9 25 7.7 326 
2006 89 25.2 59 16.7 181 51.3 2 0.6 22 6.2 353 
2007 91 23.3 55 14.1 165 42.2 6 1.5 74 18.9 391 
2008 105 26.0 40 9.9 190 47.0 7 1.7 62 15.3 404 
2009 138 34.9 30 7.6 162 41.0 5 1.3 60 15.2 395 
2010 134 40.6 23 7.0 127 38.5 9 2.7 37 11.2 330 
2011 145 44.5 17 5.2 125 38.3 3 0.9 36 11.0 326 
2012 166 49.0 17 5.0 131 38.6 5 1.5 20 5.9 339 
2013 158 46.3 21 6.2 132 38.7 3 0.9 27 7.9 341 
2014 184 48.8 27 7.2 126 33.4 2 0.5 38 10.1 377 
2015 248 51.3 49 10.1 130 26.9 5 1.0 51 10.6 483 
2016 261 51.4 21 4.1 140 27.6 3 0.6 83 16.3 508 
 
                                                                
2
 The Rainbow Clinic in Our Lady’s Children’s Hospital in Crumlin reported that there were 71 babies 
born to HIV infected mothers in Ireland during 2016. At the time of this report, (based on serial HIV 
PCR testing); 63 of these infants are not infected and 7 remain of indeterminate status (i.e. do not 
meet the criteria for HIV infection and are <18 months at time of test). There was one mother to child 
transmission of HIV in Ireland in 2016 (Personal communication; Amanda Walsh, Sept 2017) 
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Figure 3: Trend in HIV diagnoses by probable route of transmission, 2003 to 2016 
 
1.3 REGION OF BIRTH 
Twety five percent (n=129) of new diagnoses were born in Ireland, 61% (n=311) were born 
abroad and 13% (n=68) did not have information on country of birth. Of those born abroad, 
36% (n=113) were born in sub-Saharan Africa and 33% (n=103), in Latin America. Geographic 
origin varied by route of transmission (see figure 4).  
 
Figure 4: HIV diagnoses by region of birth and probable route of transmission, 2016 
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The rate of diagnosis among those born in Ireland has remained stable since 2003, ranging 
from 3.4 to 4.2 per 100,000 population (see Figure 5). There has been much greater 
fluctuation in the rate among migrants and the rate has increased from 18.4 in 2011 to 38.4 
per 100,000 in 20163.  
 
Figure 5: Trend in HIV diagnoses by migrant status, 2003 to 2016 
 
1.4 AREA OF RESIDENCE 
In 2016, 360 new HIV cases were diagnosed in people living in HSE East giving a rate of 21 per 
100,000 population. This was almost twice the national rate (see Table 4 and Figure 6).   
 
Table 4: Number and rate of HIV diagnoses by HSE area of residence4, 2016 
HSE Area Counties Number % of total Rate per 
100,000 
East Dublin, Kildare, Wicklow 360 70.9 21.0 
Midlands Laois, Longford, Offaly, Westmeath  14 2.8 4.8 
Midwest Limerick, Clare, Tipp (N) 22 4.3 5.7 
Northeast Louth, Meath, Cavan, Monaghan  23 4.5 5.0 
Northwest Sligo, Leitrim, Donegal  5 1.0 1.9 
Southeast Wexford, Waterford, Carlow, Kilkenny, Tipp (S) 13 2.6 2.5 
South Cork, Kerry 51 10.0 7.4 
West Galway, Mayo, Roscommon 20 3.9 4.4 
Total  508 100.0 10.7 
 
                                                                
3
 Rates based on total Irish born and migrant populations taken from the 2006, 2011 and 2016 census 
4
 If information on area of residence is not available, cases are assigned to the HSE area of the clinician or the 
laboratory. 
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Figure 6: Trend in the rate of HIV diagnoses by area of residence, 2014 to 2016 
 
1.5 PREVIOUSLY TESTED POSITIVE ABROAD INCLUDING TRANSFER OF CARE 
Notifications of HIV include all people who are diagnosed HIV positive for the first time in 
Ireland and include a number of people who have been previously diagnosed HIV positive 
abroad. Among the diagnoses in 2016, just over a third (34%; n=175) were previously 
diagnosed with HIV in another country (12% of these people were born in Ireland). The 
number previously positive has continued to increase in recent years (see figure 7). In 2016, 
the number of cases who had no previous history of HIV diagnosis abroad, and whose first HIV 
diagnosis was in Ireland decreased by 6% compared to 2015 (from 354 to 333 cases).  
 
 
Figure 7: Trend in HIV diagnoses by history of previous positive diagnosis, 2012 to 2016 
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The change in case definition in January 2015 may account for some of the increase in this 
number, as those known to have been previously treated abroad, may not have been included 
in surveillance prior to 2015 (as may not have had two confirmatory tests), but are now 
included in the national figures.  
 
New cases (not previously diagnosed abroad) in MSM dropped by 14% in 2016, compared to 
2015 (see Figure 8). In 2016, MSM were the group with the highest number and proportion 
(n=110; 42%) previously diagnosed HIV positive abroad and this number has increased steeply 
since 2014.  
 
 
 
Figure 8: Trend in proportion previously HIV positive by route of transmission, 2012 to 2016 
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another country to a service within Ireland. Thirty percent of people (n=151) diagnosed in 
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1.6 STAGE OF HIV INFECTION  
 
Clinical stage of Infection 
Of the 2016 diagnoses, 52% (n=264) were asymptomatic, 12% (n=62) were symptomatic (non-
AIDS), 3% (n=14) had an AIDS-defining illness, 1% (n=7) had an acute sero-conversion illness, 
and the clinical stage was not reported for the remaining 32% (n=161).  
 
Of the 14 people with an AIDS defining illness at the time of HIV diagnosis, eight were 
heterosexual and six were MSM.  
 
Late presentation and Advanced HIV infection 
Late Diagnosis: CD4 count of less than 350 cells/µl at diagnosis or an AIDS defining illness at 
diagnosis (excluding those with evidence of acute infection5) 
Advanced HIV Infection: CD4 count of less than 200 cells/µl at diagnosis or an AIDS defining 
illness at diagnosis (excluding those with evidence of acute infection8) 
 
Of all people diagnosed with HIV in Ireland in 2016, 37% were late presenters and 19% had 
advanced HIV infection (where information on CD4 count or AIDS defining illness at diagnosis 
was available). The proportion presenting late is lower than in recent years (45% in 2015, 47% 
in 2014 and 49% in 2013) and the proportion presenting with advanced infection is also lower 
compared to previous years (23% in 2015, 27% in 2014 and 26% in 2013). However, 
information on stage of diagnosis (CD4 count at diagnosis or AIDS defining illness) was 
available for 63% of cases in 2016 which is considerably less than in previous years (74% in 
2015; 88% in 2014). 
 
Considering the high proportion of people diagnosed with HIV in Ireland who were previously 
diagnosed HIV positive abroad, these groups were separated when analysing late 
presentation. The proportion of people who presented late among those who were not 
reported to have a previous diagnosis abroad was 44%. The proportion of people who 
                                                                
5
 P24 antigen positive or clinical diagnosis of acute sero-conversion illness 
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presented with advanced HIV infection among those without a previous positive diagnosis was 
24%.  
 
Table 5 presents the proportion presenting late among (a) all diagnoses in 2016 and (b) among 
those who were not previously diagnosed HIV positive abroad and Table 6 presents the 
proportion presenting with advanced HIV infection among (a) all diagnoses in 2016 and (b) 
among those who were not previously diagnosed HIV positive abroad. 
 
The groups with the highest proportions both presenting late and with advanced HIV infection 
were females, heterosexuals, people aged 40 years and over and people born in sub-Saharan 
Africa. 
 
Table 5: Frequency of late presentation in all 2016 HIV diagnoses and in “new” 2016 HIV 
diagnoses by gender, probable route of transmission, age group and region of origin 
 Number and Proportion presenting late 
Among all 2016 
diagnoses 
New 2016 diagnoses 
(excluding those previously 
HIV positive) 
n % n % 
Total 
  
119 37.2 87 44.2 
Gender Female 30 47.6 24 57.1 
Male 89 34.6 63 40.6 
Route of 
transmission 
MSM 61 31.3 42 36.5 
PWID 5 35.7 5 45.5 
Hetero- male 25 48.9 18 58.1 
Hetero - female 23 50.0 20 57.1 
Age Group (yrs) 20-29 28 33.7 23 39.7 
30-39 44 31.2 28 34.6 
40-49 32 50.8 22 64.7 
50+ 15 50.0 14 60.9 
Region of origin Ireland 36 38.3 32 39.0 
Europe 20 35.1 11 37.9 
Latin America 23 28.0 15 46.9 
Sub-Saharan Africa 36 52.9 26 56.5 
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Table 6: Frequency of advanced HIV disease in all 2016 HIV diagnoses and in “new” 2016 HIV 
diagnoses by gender, probable route of transmission, age group and region of origin 
 Number and Proportion presenting with advanced HIV infection 
Among all 2016 diagnoses  New 2016 diagnoses (excluding 
those previously HIV positive) 
n % n % 
Total 61 19.0 47 23.7 
Gender Female 20 31.7 16 38.1 
Male 41 15.9 31 19.9 
Route of 
transmission 
MSM 27 13.8 20 17.4 
PWID 1 7.1 1 9.1 
Hetero- male 13 27.7 10 32.3 
Hetero - female 18 36.0 15 42.9 
Age Group 
(yrs) 
20-29 7 8.4 7 12.1 
30-39 28 19.9 19 23.5 
40-49 16 25.0 11 31.4 
50+ 10 33.3 4 50.0 
Region of 
origin 
Ireland 22 23.2 21 25.3 
Europe 11 19.3 5 17.2 
Latin America 7 8.5 5 15.6 
Sub-Saharan Africa 19 27.9 14 30.4 
 
1.7 CO-INFECTIONS 
Among MSM, 22% were co-infected with an acute bacterial STI (chlamydia, gonorrhoea 
and/or early infectious syphilis). Over 90% of PWID were co-infected with hepatitis C and 6% 
of heterosexuals were co-infected with TB (see Table 6 for data on co-infections by probable 
route of transmission).  
 
Table 6: Co-infections with HIV by probable route of transmission, 20166 
 MSM Hetero PWID Total 
Co-infection with  No.  %  No.  % No. % No.  % 
Acute STI  57 21.8 7 5.0 0 0.0 66 13.0 
Chlamydia 23 8.8 2 1.4 0 0.0 25 4.9 
Gonorrhoea 23 8.8 0 0.0 0 0.0 23 4.5 
Acute Infectious Syphilis 28 10.7 5 3.6 0 0.0 35 6.9 
TB 4 1.5 8 5.7 0 0.0 12 2.4 
Hepatitis B (all stages)  7 2.7 5 3.6 1 4.8 15 3.0 
Hepatitis C (all stages) 11 4.2 1 0.7 19 90.5 33 6.5 
                                                                
6
 Data on co-infections are obtained from data provided on the HIV enhanced surveillance form. 
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2. LABORATORY DATA 
 
HIV testing data 
In 2016, there were 192,956 HIV tests carried out in 12 laboratories in Ireland7,  giving a 
testing rate of 40.5 per 1,000 population. This compares to 38.9 per 100,000 in 2015. There 
were 117,589 tests among females and 74,218 tests among males (1,149 gender unknown), 
giving a testing rate of 48.8 per 1,000 among females and 31.5 per 1,000 among males. The 
higher rate of testing in females reflects the HIV antenatal screening programme. It is 
important to note that the calculated testing rate are likely to over-estimate the true rate of 
testing in the population as the numbers reported are not of individuals who have been tested 
but of tests performed and can include repeat tests on the same individual.  
 
3. DEATHS DUE TO HIV AND AIDS IN 2016 
Data on deaths are obtained from (a) clinicians reports via the enhanced surveillance form 
and (b) data reported to the CSO. It is not possible to link the two sources of information.  
 
3.1 Data from enhanced surveillance forms 
Among the HIV diagnoses in 2016, two people were reported to have died at the time of HIV 
notification, one male and one female (both infected through heterosexual contact).  
 
3.2 Data from CSO Vital Statistics report 8 
There were eight deaths reported to the CSO in 2016 where the cause of death was AIDS or 
HIV, four males and four females.  
 
                                                                
7
 Hospitals which provided 2016 HIV testing data: Biomnis Laboratory, Dublin; Bon Secours, Cork; Galway Clinic; 
Galway University Hospital; Mercy University Hospital, Cork; University Hospital Limerick; National Virus 
Reference Laboratory;  Portiuncula Hospital, Galway; Rotunda Maternity Hospital, Dublin; St James's Hospital, 
Dublin; Waterford Regional Hospital; Sligo Regional Hospital 
8
 Source: Vital Statistics Reports, CSO available at  
http://www.cso.ie/en/releasesandpublications/ep/p-vsys/vitalstatisticsyearlysummary2015/  
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4. MEN WHO HAVE SEX WITH MEN (MSM) 
MSM remain the population most affected by HIV in Ireland. In 2016, there were 261 new HIV 
diagnoses reported among MSM which was just over half (51%) of all diagnoses in 2016 (see 
Table 7 for key characteristics). While the number of diagnoses in 2016 is the highest number 
ever reported among MSM in Ireland,  it is important to note that 42% of MSM diagnosed 
with HIV in Ireland in 2016 had a previous HIV diagnosis abroad and 87% of these men had 
transferred their HIV care from abroad to Ireland. Among MSM without a previous HIV 
positive diagnosis, there was a 14% decrease between 2015 and 2016.  
 
Table 7: Characteristics of HIV diagnoses among MSM, 2016 
 
Age Median age (years) 33 
Age range of adult cases (years) 19-74 
Young people aged 15-24 years (%) 8.4 
Aged 50 and older (%) 9.2 
Geographic origin Born in Ireland (%) 31.8 
Born Abroad (%) 63.2 
Unknown (%) 5.0 
Stage of Infection 9 
(of those with CD4 count at 
diagnosis reported) 
Late (<350 cells/µl or AIDS) (%) 31.3 
Advanced HIV infection (<200 cells/µl or AIDS) (%) 13.8 
Concurrent AIDS diagnosis (%) 2.3 
Co-infections Acute STI (%) 21.8 
Gonorrhoea 8.8 
Chlamydia 8.8 
Early infectious syphilis 10.7 
Previous history of testing Previously tested positive abroad (%) 42.1 
Transfer of care (of those with a prev positive 
diagnosis) (%) 
87.3 
 
 
 
 
 
                                                                
9
 Stage of infection of all HIV diagnoses among MSM in 2016 (see Table 5 on page 15 for analysis among those 
without a previous positive diagnosis) 
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5. HETEROSEXUALS 
Heterosexual transmission accounted for 28% of HIV diagnoses in 2016, with 79 diagnoses 
among females and 61 among males (see table 8). Heterosexual contact is the most common 
HIV transmission method among women and the second most common among men. Since 
2010, the number of diagnoses among heterosexuals has remained stable (ranging from 125 
to 140 cases).  
 
Of note, 37% of heterosexual cases were previously diagnosed HIV positive abroad and 88% of 
these people transferred their care to Ireland. The majority of heterosexual cases were born 
in sub-Saharan Africa, an area of the world which has a generalised HIV epidemic (>1% of the 
general population with HIV).  
 
Table 8: Characteristics of HIV diagnoses among male and female heterosexuals, 2016 
 Male Female 
Total number 61 79 
Age Median age (years) 39 36 
Age range (years) 23-67 20-60 
Young people aged 15-24 years (%) 6.6 7.6 
Aged 50 and older (%) 16.4 5.1 
Geographic origin Ireland (%) 29.5 7.6 
Sub-Saharan Africa (%) 45.9 78.5 
Other (%) 23.0 8.9 
Unknown (%) 1.6 5.1 
Stage of Infection10 
(of those with CD4 count 
at diagnosis reported) 
Late (<350 cells/µl) (%) 48.9 50.0 
Advanced HIV infection (<200 cells/µl) (%) 27.7 36.0 
Concurrent AIDS diagnosis (%) 6.6 5.1 
Co-infections Acute STI (%)  9.8 1.3 
TB (%) 3.3 7.6 
Previous history of 
testing 
Previously tested positive abroad (%) 34.4 39.2 
 Transfer of care (of those with a previous 
positive diagnosis abroad) (%) 
90.5 87.1 
 
 
 
                                                                
10
 Stage of infection of all HIV diagnoses in heterosexuals in 2016 (see Table 5 on page 15 for analysis among 
those without a previous positive diagnosis) 
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6. PEOPLE WHO INJECT DRUGS (PWID) 
There were 21 new diagnoses (4%) among PWID in 2016, 15 (71%) among males and six (29%)  
among females (see Table 9 for key characteristics). This is a decrease compared to the 
number of diagnoses among PWID in 2014 (n=27) and 2015 (n=49) when there was an 
outbreak of HIV among PWID living in Dublin (4, 5). The outbreak was declared over in 
February 2016.  
 
Table 9: Characteristics of HIV diagnoses among PWID, 2016 
Age Median age of adult cases (years) 35 
Age range of adult cases (years) 20-59 
Young people aged 15-24 years (%) 9.5 
Aged 50 and older (%) 4.8 
Geographic origin Born in Ireland (%) 71.4 
Born Abroad (%) 23.8 
Unknown (%) 4.8 
Stage of Infection11 
(of those with CD4 count at 
diagnosis reported) 
Late (<350 cells/µl) (%) 35.7 
Advanced HIV infection (<200 cells/µl) (%) 7.1 
P24 antigen positve (indicating acute infection) 0.0 
Co-infections Hepatitis C (%) 90.5 
 Previous history of testing Previously tested positive abroad (%) 14.3% 
 
 
 
 
 
 
 
                                                                
11
 Stage of infection of all HIV diagnoses in PWID in 2016 (see Table 5 on page 15 for analysis among those 
without a previous positive diagnosis) 
  
21 
 
TECHNICAL NOTES 
1.  In January 2015, there was a change to the surveillance case definition for HIV for HSE 
East (Dublin, Kildare and Wicklow). Previously, confirmatory testing by the NVRL was 
required on two separate samples prior to notification. From January 2015 onwards, 
confirmatory testing by NVRL on one sample was sufficient prior to notification. This 
change was applied to notifications from all other HSE areas in January 2016.  
2.  Rates were calculated using census data; 2016 census data for 2014-2016; 2011 census 
data for 2009-2013; and 2006 census data for 2003-2008.  
4.  Data for this report were extracted from CIDR on 23rd August 2017 and were correct at 
the time of publication.  
5.  Data from previous years is updated on an ongoing basis in CIDR, and so data from 
previous years in this report represents our most up to date data, and may not 
correspond exactly with what was reported previously.  Similarly, data for 2016 may be 
updated further in due course and will be reported on in subsequent annual reports 
6.  Percentages are rounded up in the text and provided to one decimal place in tables. 
7.  For the purposes of this report, “Mother to Child Transmission” cases were included in 
the category “Unk/Other” for many of the tables and figures.   
8.  Data are presented by date of notification 
 
FURTHER INFORMATION 
 Weekly, 6 monthly and annual reports on the epidemiology of HIV in Ireland can be 
found at http://www.hpsc.ie/a-z/hivstis/hivandaids/hivdataandreports/  
 The case definition for HIV can be found at 
http://www.hpsc.ie/notifiablediseases/casedefinitions/   
 The HIV enhanced surveillance form can be found at  
http://www.hpsc.ie/notifiablediseases/notificationforms/   
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APPENDIX 1: ADDITIONAL TABLES 
 
Table A1: Data completeness of key variables in 2016 
 Completeness in 2016 
 Number  % 
Probable route of transmission 427 84.1 
Country of birth 440 86.6 
Previously HIV positive 400 78.7 
CD4 count at diagnosis 321 63.2 
Viral load at diagnosis 263 51.8 
Clinical stage 347 68.4 
 
Table A2: HIV diagnoses by probable route of transmission and gender, 2016 
 Male Female Total 
MSM 261 66.4 - - 261 51.4 
Hetero 61 15.5 79 68.7 140 27.6 
PWID 15 3.8 6 5.2 21 4.1 
MTCT 0 0.0 3 2.6 3 0.6 
Unk/Other 56 14.2 27 23.5 83 16.3 
Total 393 100.0 115 100.0 508 100.0 
 
Table A3: HIV diagnoses by probable route of transmission and age group, 2016 
Age Group MSM Hetero PWID MTCT Unk/Other Total 
N % N % N % N % N % N % 
<15 0 0.0 0 0.0 0 0.0 1 33.3 0 0.0 1 0.2 
15-19  2 0.8 0 0.0 0 0.0 1 33.3 1 1.2 4 0.8 
20-24  20 7.7 10 7.1 2 9.5 0 0.0 4 4.8 36 7.1 
25-29  61 23.4 14 10.0 2 9.5 0 0.0 13 15.7 90 17.7 
30-34  64 24.5 29 20.7 4 19.0 1 33.3 12 14.5 110 21.7 
35-39  48 18.4 38 27.1 6 28.6 0 0.0 17 20.5 109 21.5 
40-44 26 10.0 18 12.9 4 19.0 0 0.0 12 14.5 60 11.8 
45-49 16 6.1 17 12.1 2 9.5 0 0.0 15 18.1 50 9.8 
>50  24 9.2 14 10.0 1 4.8 0 0.0 9 10.8 48 9.4 
Total 261 100.0 140 100.0 21 100.0 3 100.0 83 100.0 508 100.0 
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Table A4: HIV diagnoses by region of birth and gender, 2016 
Region Of Origin Male Female Total 
No. % No. % No. % 
Ireland 116 29.5 13 11.3 129 25.4 
Sub Saharan Africa 41 10.4 71 61.7 112 22.0 
Latin America 99 25.2 5 4.3 104 20.5 
Central Europe 31 7.9 1 0.9 32 6.3 
Western Europe 30 7.6 2 1.7 32 6.3 
Eastern Europe 9 2.3 2 1.7 11 2.2 
South and South East Asia 6 1.5 1 0.9 7 1.4 
Other 12 3.0 1 0.9 13 2.6 
Unknown 49 12.5 19 16.5 68 13.4 
Total 393 100.0 115 100.0 508 100.0 
 
Table A5:  HIV diagnoses by route of transmission and probable region of infection, 2016 
Probable region of 
infection 
MSM Hetero PWID Unk/Other Total 
No.  % No.  % No.  % No.  % No.  % 
Ireland 87 33.3 25 17.9 14 66.7 4 4.7 130 25.6 
Sub-Saharan Africa 5 1.9 63 45.0 0 0.0 9 10.5 77 15.2 
Western Europe 51 19.5 10 7.1 1 4.8 3 3.5 65 12.8 
Central&Eastern Europe 6 2.3 3 2.1 3 14.3 0 0.0 12 2.4 
Latin America 53 20.3 5 3.6 0 0.0 3 3.5 61 12.0 
Other 18 6.9 6 4.3 0 0.0 2 2.3 26 5.1 
Unknown 41 15.7 28 20.0 3 14.3 65 75.6 137 27.0 
Total 261 100.0 140 100.0 21 100.0 86 100.0 508 100.0 
 
Table A6: HIV diagnoses by reason for HIV test, gender and route of transmission, 2016 
Reason for Test Gender Probable route of transmission Total 
Female Male MSM Hetero PWID Unk/Other 
Antenatal 12 - - 12 - 1 13 
Asylum seeker screening 18 9 2 22 - 1 25 
Known positive partner 10 19 14 15 - - 29 
STI screen 11 92 78 19 1 4 102 
Risky behaviour 5 80 64 8 13 - 85 
Symptomatic 12 74 50 28 3 5 86 
Known positive 2 14 9 6 1 0 16 
Other 11 15 5 12 1 8 26 
Unknown 34 90 39 18 2 67 126 
Total 115 393 261 140 21 86 508 
 
Table A7: HIV diagnoses by probable route of transmission and HIV testing history, 2016 
 MSM Hetero PWID Unk/Other Total 
No % No % No % No % No % 
Prev neg in 2015/2016 56 21.5 4 2.9 4 19.0 1 1.2 65 12.8 
Prev neg pre 2015 74 28.4 26 18.6 9 42.9 4 4.7 113 22.2 
No previous neg test 42 16.1 48 34.3 4 19.0 7 8.1 101 19.9 
Unknown 89 34.1 62 44.3 4 19.0 74 86.0 229 45.1 
Total 261 100.0 140 100.0 21 100.0 86 100.0 508 100.0 
 
